[EN] PROCESS OF PREPARING PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE MALADIES À MÉDIATION ASSURÉE PAR LE CFTR
申请人:VERTEX PHARMA
公开号:WO2015073231A1
公开(公告)日:2015-05-21
Processes of preparing pharmaceutical compositions comprising 3-(6-(1-(2,2- difluorobenzo[d][1,3] dioxol-5 -yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (Compound 1) in Form I and a solid dispersion comprising substantially amorphous N-(5- hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-lH-quinoline-3-carboxamide (Compound 2), methods of treating, lessening the severity of, or symptomatically treating CFTR mediated diseases, such as cystic fibrosis, methods of administering, and kits thereof are disclosed.